Divi's Laboratories Ltd

NSE:DIVISLABHealthcareNSE:CNX100NSE:CNX200

——At close · Market cap — · Next earnings Mon 9 Nov

DIVISLAB · Ratios · TradingHolo

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	64.5%	64.9%	58.5%	58.1%	58.5%	43.2%	—	—
Operating margin	38.1%	40.6%	26.4%	23.5%	27.6%	28.2%	28.2%	+0.0 pts
Net margin	28.9%	33.6%	23.8%	20.5%	23.5%	24.3%	24.3%	+0.0 pts
EBITDA margin	42.6%	45.4%	35.4%	32.6%	35.6%	36.7%	—	—
Return on equity	21.3%	25.2%	14.3%	11.8%	14.6%	15.3%	15.3%	+0.0 pts
Return on assets	18.4%	22.1%	12.6%	10.3%	12.9%	12.8%	12.8%	+0.0 pts
Return on capital employed	27.1%	29.3%	15.2%	12.9%	16.6%	16.6%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	1,251.7×	1,795.9×	1,034.2×	610.7×	857.0×	129.5×	—	—
Current ratio	5.6×	7.0×	8.5×	7.6×	6.9×	5.4×	5.4×	+0.0%
Quick ratio	3.6×	4.6×	5.7×	5.1×	4.7×	3.5×	—	—
Cash ratio	1.8×	1.0×	0.2×	0.3×	0.3×	1.7×	1.7×	+0.0%
Asset turnover	0.6×	0.7×	0.5×	0.5×	0.6×	0.5×	—	—
Inventory turnover	1.1×	1.1×	1.1×	1.0×	1.2×	1.5×	—	—
Receivables turnover	4.2×	3.6×	4.3×	3.6×	3.1×	3.5×	—	—
Dividend payout	0.0%	17.9%	43.7%	49.8%	36.3%	31.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.